Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation

Remi A. Nout*, Tjalling Bosse, Carien L. Creutzberg, Ina M. Jurgenliemk-Schulz, Jan J. Jobsen, Ludy C. H. W. Lutgens, Elzbieta M. van der Steen-Banasik, Ronald van Eijk, Natalja T. ter Haar, Vincent T. H. B. M. Smit

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

42 Citations (Web of Science)
Original languageEnglish
Pages (from-to)466-473
JournalGynecologic Oncology
Issue number3
Publication statusPublished - Sep 2012


  • Endometrial cancer
  • Oncogenic pathway alterations
  • PI3K-AKT pathway
  • Wnt signaling pathway
  • Microsatellite-instability
  • P53 mutation

Cite this